Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRU-015 in active seropositive rheumatoid arthritis
NCT00634933Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Mar 2008
- Primary completion
- Feb 2010
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 2 trial of tru-015 in rheumatoid arthritis (RA), sponsored by Pfizer. Started Mar 2008; status: terminated.
02
Drugs
tru-015
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00634933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634933.